Ghent University Academic Bibliography

Journal Article
A1
open access

Deep brain stimulation of the anterior nucleus of the thalamus in drug resistant epilepsy in the MORE multicenter patient registry

J Peltola, AJ Colon, J Pimentel, VA Coenen, A Gil-Nagel, AG Ferreira, K Lehtimäki, P Ryvlin, RS Taylor, L Ackermans, et al.

(2023) NEUROLOGY. 100(18). p.E1852-E1865

Add to list

Disease reactivation after cessation of disease-modifying therapy in patients with relapsing-remitting multiple sclerosis

I Roos, C Malpas, E Leray, R Casey, D Horakova, EK Havrdova, M Debouverie, F Patti, J De Seze, G Izquierdo, et al.

(2022) NEUROLOGY. 99(17). p.E1926-E1944

Add to list

Association of latitude and exposure to ultraviolet B radiation with severity of multiple sclerosis : an international registry study

M Vitkova, I Diouf, C Malpas, D Horakova, E Kubala Havrdova, F Patti, S Ozakbas, G Izquierdo, S Eichau, V Shaygannejad, et al.

(2022) NEUROLOGY. 98(24). p.E2401-E2412

Add to list

Efficacy and safety of Bimagrumab in sporadic inclusion body myositis : long-term extension of RESILIENT

AA Amato, MG Hanna, PM Machado, UA Badrising, H Chinoy, O Benveniste, AK Karanam, M Wu, LB Tankó, AA Schubert-Tennigkeit, et al.

(2021) NEUROLOGY. 96(12). p.e1595-e1607

Add to list

Journal Article
A1
open access

Post-intervention status in patients with refractory myasthenia gravis treated with eculizumab during REGAIN and its open-label extension

R Mantegazza, GI Wolfe, S Muppidi, H Wiendl, KP Fujita, FL O'Brien, Booth HDE, JF Howard, REGAIN Study Group and Jan De Bleecker (UGent)

(2021) NEUROLOGY. 96(4). p.E610-E618

Add to list

Journal Article
A1
open access

Efficacy and safety of rozanolixizumab in moderate to severe generalized myasthenia gravis : a phase 2 randomized control trial

V Bril, M Benatar, H Andersen, J Vissing, M Brock, B Greve, P Kiessling, F Woltering, L Griffin, P Van den Bergh, et al.

(2021) NEUROLOGY. 96(6). p.E853-E865

Add to list

Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease

Enrica Cavedo, Simone Lista, Marion Houot, Andrea Vergallo, Michel J. Grothe, Stefan Teipel, Henrik Zetterberg, Kaj Blennow, Marie-Odile Habert, Marie C. Potier, et al.

(2020) NEUROLOGY. 94(1). p.E30-E41

Add to list

Journal Article
A1
open access

Multisystem proteinopathy due to a homozygous p.Arg159His VCP mutation : a tale of the unexpected

W De Ridder, A Azmi, CS Clemen, L Eichinger, A Hofmann, R Schröder, K Johnson, A Töpf, V Straub, P De Jonghe, et al.

(2020) NEUROLOGY. 94(8). p.785-796

Add to list

Journal Article
A1
open access

Clinical trials of disease-modifying agents in pediatric MS : opportunities, challenges, and recommendations from the IPMSSG

Emmanuelle Waubant, Brenda Banwell, Evangeline Wassmer, Maria-Pia Sormani, Maria-Pia Amato, Rogier Hintzen, Lauren Krupp, Kevin Rostásy, Silvia Tenembaum, Tanuja Chitnis, et al.

(2019) NEUROLOGY. 92(22). p.e2538-e2549

Add to list

Idiopathic inflammatory myopathy : interrater variability in muscle biopsy reading

Pieter Olivier, Boel De Paepe (UGent) , Eleonora Aronica, Florieke Berfelo, Roos Colman (UGent) , Anthony Amato, Dalia Dimitri, Eduard Gallardo, Romain Gherardi, Hans-Hilmar Goebel, et al.

(2019) NEUROLOGY. 93(9). p.e889-e894

Academic Bibliography

Deep brain stimulation of the anterior nucleus of the thalamus in drug resistant epilepsy in the MORE multicenter patient registry

Disease reactivation after cessation of disease-modifying therapy in patients with relapsing-remitting multiple sclerosis

Association of latitude and exposure to ultraviolet B radiation with severity of multiple sclerosis : an international registry study

Efficacy and safety of Bimagrumab in sporadic inclusion body myositis : long-term extension of RESILIENT

Post-intervention status in patients with refractory myasthenia gravis treated with eculizumab during REGAIN and its open-label extension

Efficacy and safety of rozanolixizumab in moderate to severe generalized myasthenia gravis : a phase 2 randomized control trial

Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease

Multisystem proteinopathy due to a homozygous p.Arg159His VCP mutation : a tale of the unexpected

Clinical trials of disease-modifying agents in pediatric MS : opportunities, challenges, and recommendations from the IPMSSG

Idiopathic inflammatory myopathy : interrater variability in muscle biopsy reading

Contents

Support

Contact